Synapse

← npj Metabolic Health and Disease

Papers in npj Metabolic Health and Disease

Page 2 · newest first

  1. Deletion of cardiac fibroblast growth factor-23 beneficially impacts myocardial energy metabolism in left ventricular hypertrophynpj Metabolic Health and Disease · 2025
  2. Maternal postpartum sedentary life exacerbates the metabolic impact of moderately fat-rich diet in male micenpj Metabolic Health and Disease · 2025
  3. Adolescence as a key developmental window for nutrition promotion and cardiometabolic disease preventionnpj Metabolic Health and Disease · 2025
  4. Sterile inflammation in MASH: emerging role of extracellular RNA and therapeutic strategiesnpj Metabolic Health and Disease · 2025
  5. Mitochondrial uncoupling, energy substrate utilization, and brown adipose tissue as therapeutic targets in cancernpj Metabolic Health and Disease · 2025
  6. GLP-1 receptor agonism results in reduction in hepatic ethanol metabolismnpj Metabolic Health and Disease · 2025
  7. Metabolomic-based aging clocksnpj Metabolic Health and Disease · 2025
  8. Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFSnpj Metabolic Health and Disease · 2025
  9. The metabolic advantage of being young and male in obesity treatment outcomes in micenpj Metabolic Health and Disease · 2025
  10. Cave adaptation favors aging resilience in the Mexican tetranpj Metabolic Health and Disease · 2025
  11. Skeletal muscle proteomics: considerations and opportunitiesnpj Metabolic Health and Disease · 2025
  12. Complex interaction of waist circumference, cardiometabolic markers, and sex on elderly mortality: a cohort study of 0.4 million UK adultsnpj Metabolic Health and Disease · 2025
  13. SGLT2 inhibitors across various patient populations in the era of precision medicine: the multidisciplinary team approachnpj Metabolic Health and Disease · 2025
  14. Aspirin reduces the risk of type 2 diabetes associated with COVID-19npj Metabolic Health and Disease · 2025
  15. The role of NAD+ metabolism and its modulation of mitochondria in aging and diseasenpj Metabolic Health and Disease · 2025
  16. ECM formation and degradation during fibrosis, repair, and regenerationnpj Metabolic Health and Disease · 2025
  17. Mechanisms and implications of the gut microbial modulation of intestinal metabolic processesnpj Metabolic Health and Disease · 2025
  18. FGF21 deletion mildly exacerbates hepatic dysfunction in GAN diet and alcohol fed ratsnpj Metabolic Health and Disease · 2025
  19. High protein intake causes gene-length-dependent transcriptional decline, shortens lifespan and accelerates ageing in progeroid DNA repair-deficient micenpj Metabolic Health and Disease · 2025
  20. Characterization and treatment monitoring of ureagenesis disorders using stable isotopesnpj Metabolic Health and Disease · 2025
  21. Comparison of polygenic risk scores for type 2 diabetes developed from different ancestry groupsnpj Metabolic Health and Disease · 2025
  22. Metagenomic analysis revealing links between age, gut microbiota and bone loss in Chinese adultsnpj Metabolic Health and Disease · 2025
  23. Clinical associations and potential cellular mechanisms linking G6PD deficiency and atherosclerotic cardiovascular diseasenpj Metabolic Health and Disease · 2025
  24. Potential bidirectional communication between the liver and the central circadian clock in MASLDnpj Metabolic Health and Disease · 2025
  25. Periodic dietary restriction of animal products induces metabolic reprogramming in humans with effects on cardiometabolic healthnpj Metabolic Health and Disease · 2025
  26. mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetesnpj Metabolic Health and Disease · 2025
  27. Ultra-processed food consumption affects structural integrity of feeding-related brain regions independent of and via adipositynpj Metabolic Health and Disease · 2025
  28. Longitudinal association of metabolic dysfunction-associated fatty liver disease, serum metabolites, with cognitive function trajectoriesnpj Metabolic Health and Disease · 2025
  29. Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progressionnpj Metabolic Health and Disease · 2025
  30. Pulling back the mitochondria’s iron curtainnpj Metabolic Health and Disease · 2025
  31. Regulation of gene expression through protein-metabolite interactionsnpj Metabolic Health and Disease · 2025
  32. AMPK phosphosite profiling by label-free mass spectrometry reveals a multitude of mTORC1-regulated substratesnpj Metabolic Health and Disease · 2025
  33. Reversal of metformin’s anti-proliferative effect in fission yeast efr3 and dnm1 (DRP1) mutants with elongated mitochondrianpj Metabolic Health and Disease · 2025
  34. Calcium-mediated regulation of mitophagy: implications in neurodegenerative diseasesnpj Metabolic Health and Disease · 2025
  35. Reshaping lipid metabolism with long-term alternate day feeding in type 2 diabetes micenpj Metabolic Health and Disease · 2025
  36. Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularizationnpj Metabolic Health and Disease · 2025
  37. RNA-binding proteins as versatile metabolic regulatorsnpj Metabolic Health and Disease · 2025
  38. Intermittent fasting as a treatment for obesity in young people: a scoping reviewnpj Metabolic Health and Disease · 2024
  39. The effect of high-sugar feeding on rodent metabolic phenotype: a systematic review and meta-analysisnpj Metabolic Health and Disease · 2024
  40. Chain splitting of insulin: an underlying mechanism of insulin resistance?npj Metabolic Health and Disease · 2024
  41. Too old for healthy aging? Exploring age limits of longevity treatmentsnpj Metabolic Health and Disease · 2024
  42. Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseasesnpj Metabolic Health and Disease · 2024
  43. SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidationnpj Metabolic Health and Disease · 2024
  44. Human adipose depots’ diverse functions and dysregulations during cardiometabolic diseasenpj Metabolic Health and Disease · 2024
  45. Variable bioenergetic sensitivity of neurons and astrocytes to insulin and extracellular glucosenpj Metabolic Health and Disease · 2024
  46. Incretin-based therapies for the treatment of obesity-related diseasesnpj Metabolic Health and Disease · 2024
  47. Sex-specific regulation of the cardiac transcriptome by the protein phosphatase 2A regulatory subunit B55αnpj Metabolic Health and Disease · 2024
  48. Ketone body metabolism and cardiometabolic implications for cognitive healthnpj Metabolic Health and Disease · 2024
  49. Hypothalamic neuronal-glial crosstalk in metabolic diseasenpj Metabolic Health and Disease · 2024
  50. Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trialnpj Metabolic Health and Disease · 2024